Publications and Presentations

Avoiding Missed Opportunities by Analysing the Sensitivity of our Decisions

Summary

There are a number of criteria to balance when looking to select a successful drug candidate. But how can we consider the impact of the compound selection criteria we choose on the decisions we make?

This peer-reviewed article, published in the Journal of Medicinal Chemistry, describes how identifying sensitive criteria can highlight new avenues for exploration, and assist us in avoiding missed opportunities.

avoiding missed opportunities by analysing the sensitivity of our decisions

Citation details

M. D. Segall, I. Yusof, and E. J. Champness, J. Med. Chem. 2016, 59, 9, 4267–4277

DOI: 10.1021/acs.jmedchem.5b01921

 

Find out more

Read the final version of this article on the journal webpage, or for more information, watch our webinar recording.

INTERESTED IN DRUG OPTIMIZATION?

Discover StarDrop™

With its comprehensive suite of integrated software, StarDrop™ delivers best-in-class in silico technologies within a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through predictive modelling to decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the drug optimisation and discovery process.